(2R,3R)‐2‐(3′,4′‐dihydroxybenzyl)‐3‐(3″,4″‐dimethoxybenzyl)butyrolactone(PP‐6) suppresses fMLP‐induced superoxide production by inhibiting fMLP‐receptor binding in human neutrophils